Ann: CEO AGM Presentation, page-9

Hey Hevlet - agree, its getting exciting. I also liked this slide. It marries up to their MST revenue predictions for 1H CY23 of $1.6m.
And I also spoke to Leearne last Friday and I mentioned the MST revenue expectations for FY 23 ($1.6m) and FY24 (up to $12.1m). Big jumps in revenue for a company with a market cap of around $50m!!. She said the revenues will come from Exo and the Monitoring using SubB2m.

There has been some excellent positive news building over the last 6 months (no hoopla from the company, but absolutely solid progress). So we are really getting close to the pointy end, and I feel this stock is primed for some good moves up. If these announcements and sales start to come to fruition over the next 6 months...it will only be the start I feel as their pipeline for news is big and deep. Ongoing announcements about SubB2m monitoring sales, more exonet sales and progress with UOQ Ovarian test and the pan cancer test with Nicoya etc etc.. It feels like the share price is primed for a sustainable and upward run I feel. I'm even tempted to sell some of my PNV to buy more of these (and I love my PNV!!!), not sure if I will though!! GLTAH